Craig N Morrell

Title: Craig N Morrell: Innovator in Thrombotic Disease Research

Introduction

Craig N Morrell is a notable inventor based in Brighton, NY (US). He has made significant contributions to the field of medical research, particularly in the area of thrombotic diseases. With a total of 2 patents, his work focuses on innovative methods and compositions that aim to improve patient outcomes.

Latest Patents

Morrell's latest patents include groundbreaking inventions such as "Glutamate receptor antagonists and methods of use." This invention relates to methods and compositions for modulating platelet activity by inhibiting or activating glutamate receptors. The invention further addresses the prevention and treatment of thrombotic diseases. Another significant patent is "Inhibitors of N-ethylmaleimide sensitive factor," which provides methods and compositions for blocking exocytosis by inhibiting proteins that regulate this process. The compositions include multidomain fusion peptides that promote anticoagulation, attenuate thrombosis, and decrease heart attack severity.

Career Highlights

Craig N Morrell is affiliated with Johns Hopkins University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating thrombotic conditions, which are critical in the medical field.

Collaborations

Morrell has collaborated with esteemed colleagues such as Charles J Lowenstein and Kenji Matsushita. These partnerships have further enriched his research and contributed to the development of his patents.

Conclusion

In summary, Craig N Morrell is a distinguished inventor whose work in thrombotic disease research has led to valuable patents and collaborations. His contributions are poised to make a significant impact in the medical community.